A phase 1 multicenter clinical trial of alemtuzumab and CHOP chemotherapy for peripheral T-cell lymphomas.

被引：0
|
作者：
Buckstein, Rena
Crump, Michael
Fraser, Graeme A.
Cheung, Matthew C.
Piliotis, Eugenia
Imrie, Kevin
Kukreti, Vishal
Kuruvilla, John
Meyer, Ralph M.
Windsor, Jolanta
Pond, Gregory Russell
Pritchard, Kathleen I.
Levine, Mark Norman
机构：
[1] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON M4N 3M5, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[3] McMaster Univ, Hamilton, ON, Canada
[4] Princess Margaret Canc Ctr, Univ Hlth Network, Toronto, ON, Canada
[5] Juravinski Canc Ctr, Hamilton, ON, Canada
[6] McMaster Univ, Ontario Clin Oncol Grp, Hamilton, ON, Canada
[7] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[8] Univ Toronto, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.8551
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8551
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707
    Maeda, Yoshinobu
    Nishimori, Hisakazu
    Yoshida, Isao
    Hiramatsu, Yasushi
    Uno, Masatoshi
    Masaki, Yasufumi
    Sunami, Kazutaka
    Masunari, Taro
    Nawa, Yuichiro
    Yamane, Hiromichi
    Gomyo, Hiroshi
    Takahashi, Tsutomu
    Yano, Tomofumi
    Matsuo, Keitaro
    Ohshima, Koichi
    Nakamura, Shigeo
    Yoshino, Tadashi
    Tanimoto, Mitsune
    HAEMATOLOGICA, 2017, 102 (12) : 2097 - 2103
  • [42] A Multicenter, Phase III Study of Chidamide, Azacitidine Combined with CHOP Versus CHOP in Patients with Untreated Peripheral T-Cell Lymphoma
    Wei, Chong
    Zhang, Yan
    Li, Jian
    Zhang, Wei
    Zhou, Daobin
    BLOOD, 2022, 140 : 6567 - 6568
  • [43] Immune response in primary cutaneous T-cell lymphomas.
    Asadullah, K
    Friedrich, M
    Docke, WD
    Jahn, S
    Volk, HD
    Sterry, W
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) : 140 - 140
  • [44] Cytotoxic protein expression in cutaneous T-cell lymphomas.
    Boulland, ML
    Gaulard, P
    Delfau, MH
    Bagot, M
    Wechsler, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) : 489 - 489
  • [45] Early Results of a Phase Ib/II Dose-Escalation Trial of Romidepsin in Association with CHOP in Patients with Peripheral T-Cell Lymphomas (PTCL)
    Dupuis, Jehan
    Casasnovas, Rene-Olivier
    Morschhauser, Franck
    Ghesquieres, Herve
    Thieblemont, Catherine
    Ribrag, Vincent
    Tilly, Herve
    Coiffier, B.
    BLOOD, 2011, 118 (21) : 1148 - 1148
  • [46] Overview of alemtuzumab therapy for the treatment of T-cell lymphomas
    Zinzani, Pier Luigi
    Corradini, Paolo
    Gallamini, Andrea
    Grossi, Alberto
    Lazzarino, Mario
    Marchetti, Monia
    Martelli, Maurizio
    Rossi, Giuseppe
    Vitolo, Umberto
    LEUKEMIA & LYMPHOMA, 2012, 53 (05) : 789 - 795
  • [47] Impact of high-dose chemotherapy on peripheral T-cell lymphomas
    Mounier, N
    Simon, D
    Haioun, C
    Gaulard, P
    Gisselbrecht, C
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) : 1426 - 1427
  • [48] Impact of high-dose chemotherapy on peripheral T-cell lymphomas
    Rodriguez, J
    Munsell, M
    Yazji, S
    Hagemeister, FB
    Younes, A
    Andersson, B
    Giralt, S
    Gajewski, J
    de Lima, M
    Couriel, D
    Romaguera, J
    Cobanillas, FF
    Champlin, RE
    Khouri, IF
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (17) : 3766 - 3770
  • [49] PERIPHERAL T-CELL LYMPHOMAS - HISTOLOGIC, IMMUNOHISTOLOGIC, AND CLINICAL CHARACTERIZATION
    WEIS, JW
    WINTER, MW
    PHYLIKY, RL
    BANKS, PM
    MAYO CLINIC PROCEEDINGS, 1986, 61 (06) : 411 - 426
  • [50] Management of Mucositis with the Use of Leucovorin As Adjunct to Pralatrexate in Treatment of Peripheral T-Cell Lymphomas (PTCL) - Results from a Prospective Multicenter Phase 2 Clinical Trial
    Shustov, Andrei R.
    Shinohara, Michi M.
    Dakhil, Shaker R.
    Bhat, Gajanan
    Zain, Jasmine M.
    BLOOD, 2018, 132
12345